Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Apnimed
Biotech
Shionogi pays Apnimed $100M for sleep disorder joint venture
Shionogi is taking full control of its sleep disorder joint venture, agreeing to pay Apnimed $100 million upfront for its partner’s stake.
Nick Paul Taylor
Mar 24, 2026 9:20am
Apnimed's sleep apnea star goes 2 for 2 in phase 3
Jul 23, 2025 6:00am
Apnimed eyes FDA sleep apnea submission after positive results
May 19, 2025 6:00am
Pfizer's migraine market chief joins Apnimed—Chutes & Ladders
Jan 26, 2024 9:30am
Two biotechs go public while Apnimed bides its time
Oct 2, 2023 11:02am
Apnimed nails study of sleep apnea med, tees up phase 3 test
May 22, 2023 10:45am